Tamoxifen inducible Cre (CreERT2-RFP) Adenovirus (Ad-RFP-CreERT2)

Mfr.No.	1797
Description	A mutated form of estrogen ligand-binding domain (ERT2) that binds to synthetic antagonists (such as tamoxifen or its derivative 4-hydroxy-tamoxifen) but not to circulating estrogens was fused to the Cre recombinase (Cre) to create the CreERT2, which requires the presence of tamoxifen for Cre recombinase activity. Therefore it makes possible to induce the recombination in cells with tamoxifen.This adenovirus expresses both CreERT2 and RFP under the same CMV promoter, and the 2 genes are separated by a 2A polypeptide.
Categories	Adenovirus, Over-Expression, Recombinase
Product Type	Pre-Made
Virus Type	Adenovirus
Function	Reporter/Tag
Promoter	CMV (ubiquitous)
Reporter	RFP
Storage Buffer	DMEM, 2% BSA, 2.5% Glycerol
Viral Backbone	Human Adenovirus Type5 (dE1/E3)
Shelf Life	12 Months
HS Code	3822190000
UNSPSC Code	41106621
Insert Gene	RFP-CreERT2
Availability	Ready to Ship
Titer	1x10^10 PFU/ml
Reporter	RFP
Storage	-80C
Shipping	Dry Ice

Have you used this product?

SKU	Supplier No.	Size	Your price	Quantity
BHV21600365	1797	200 µL	$495		Add to Cart